Core Insights - Clarivate Plc has announced a new subscription-based content access strategy aimed at providing broad, simple, and affordable access to trusted scholarly content for libraries, enhancing research, teaching, and learning goals [1][4] Industry Trends - The purchasing models for academic content by institutions have evolved, particularly post-pandemic, with libraries facing complex buying models that do not meet their needs for curricula and research [2] - There is a growing reliance on AI-powered chatbots for discovery among students and researchers, which necessitates access to vetted academic content [3] Company Strategy - Clarivate's new strategy includes phasing out one-time perpetual purchases of digital collections and books, transitioning to subscription models throughout 2025 in collaboration with libraries [6] - The introduction of ProQuest Ebooks and ProQuest Digital Collections aims to provide extensive access to high-quality scholarly resources, including over 700,000 Ebooks and 160 million primary source items [5][8] Product Offerings - The ProQuest Ebooks subscription includes multidisciplinary scholarly Ebooks and a new Ebook Central Reader app for enhanced accessibility [8] - The ProQuest Research Assistant is designed to help students and researchers utilize academic AI responsibly, with plans for expansion to support ProQuest Digital Collections [8] Commitment to Libraries - Clarivate emphasizes its commitment to working closely with libraries and publishers to meet the evolving needs of the academic community [9]

Analysts on Wall Street project that Clarivate PLC (CLVT) will announce quarterly earnings of $0.20 per share in its forthcoming report, representing a decline of 13% year over year. Revenues are projected to reach $658.05 million, declining 3.8% from the same quarter last year.Over the last 30 days, there has been an upward revision of 0.7% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts ...

Highly recommended in trademark management, searching and watching, renewals and recordals LONDON, Feb. 10, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has been recognized by the World Trademark Review for three categories in the WTR 1000 2025 . This guide identifies the top trademark professionals and firms in key jurisdictions around the globe. Clarivate has been named as highly recommended in the following practice areas : Trademark Managemen ...

Software-as-a-Service, cloud-based library services and discovery platform to be implemented in nine universities and 82 academic and research libraries across Croatia LONDON, Feb. 5, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that the National and University Library in Zagreb has selected Clarivate to provide its unified library services and discovery platform. The National and University Library in Zagreb (NSK) is Croatia's le ...

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON, Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence and BioWorld by Clarivate, today published a new e-book, Pulsed field ablation: stunning growth shocks the atrial fibrillation market. The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcas ...

Core Insights - The report from Clarivate highlights the significant role of academic research in driving global innovation and societal benefits, emphasizing the collaboration between academia and industry [1][3] Group 1: Key Findings - The report identifies the top 50 universities that contribute to global innovation, based on the number of citations from patents granted to companies on the Top 100 Global Innovators 2024 list [2][5] - Harvard University ranks first, followed by Stanford University and the Massachusetts Institute of Technology (MIT), showcasing the dominance of U.S. institutions in research output [5][7] - The report notes that five organizations—Roche, Johnson & Johnson, CNRS, Samsung Electronics, and Siemens—account for over half (51%) of citations linking top innovations to academic research [5] Group 2: Implications for Stakeholders - University and research institution leaders can benchmark their impact on innovation and enhance knowledge transfer strategies [6] - R&D and innovation executives are encouraged to establish productive academic partnerships to drive innovation [6] - Policymakers and funding bodies can utilize the insights to understand how research investments translate into real-world impacts [6]

Achieving more unified and secure workflows with cloud-based Alma, Primo and Rapido library software solutions from Clarivate LONDON, Jan. 28, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces that the British Library has selected Clarivate to provide its library services and discovery platforms to create a more cohesive, streamlined and secure experience. The British Library will implement Alma, Primo VE and Rapido. Founded in 1973, th ...

LONDON, Jan. 22, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the fourth quarter and full year 2024 before the market opens on Wednesday, February 19, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern ...

Shares of Clarivate PLC (CLVT) have gained 1.6% over the past four weeks to close the last trading session at $5.08, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $6.56 indicates a potential upside of 29.1%.The average comprises eight short-term price targets ranging from a low of $4 to a high of $8, with a standard deviation of $1.45. While the lowest estimate indicates a dec ...

Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its highly anticipated 2024 Year in Review series. This multipart special report offers an in-depth analysis of the therapeutic trends, regulatory actions and economic shifts that defined biopharma, med tech and scientific innovation over the past year while fo ...